avapro has been researched along with Hypertension, Pulmonary in 3 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Myocyte apoptosis and muscle atrophy were significantly decreased with irbesartan compared with untreated CHF rats." | 5.31 | Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure. ( Angelini, A; Battista Ambrosio, G; Dalla Libera, L; Ravara, B; Rossini, K; Sandri, M; Thiene, G; Vescovo, G, 2001) |
| "Myocyte apoptosis and muscle atrophy were significantly decreased with irbesartan compared with untreated CHF rats." | 1.31 | Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure. ( Angelini, A; Battista Ambrosio, G; Dalla Libera, L; Ravara, B; Rossini, K; Sandri, M; Thiene, G; Vescovo, G, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Nijiati, Y | 1 |
| Maimaitiyiming, D | 1 |
| Yang, T | 1 |
| Li, H | 1 |
| Aikemu, A | 1 |
| Jasmin, JF | 1 |
| Calderone, A | 1 |
| Leung, TK | 1 |
| Villeneuve, L | 1 |
| Dupuis, J | 1 |
| Dalla Libera, L | 1 |
| Ravara, B | 1 |
| Angelini, A | 1 |
| Rossini, K | 1 |
| Sandri, M | 1 |
| Thiene, G | 1 |
| Battista Ambrosio, G | 1 |
| Vescovo, G | 1 |
3 other studies available for avapro and Hypertension, Pulmonary
| Article | Year |
|---|---|
Research on the improvement of oxidative stress in rats with high-altitude pulmonary hypertension through the participation of irbesartan in regulating intestinal flora.
Topics: Altitude Sickness; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Gastroi | 2021 |
Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan.
Topics: Actins; Angiotensin II Type 2 Receptor Blockers; Animals; Antigens, CD; Antigens, Differentiation, M | 2003 |
Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure.
Topics: Angiotensin II; Animals; Apoptosis; Biphenyl Compounds; Calcium Channel Blockers; Drug Evaluation, P | 2001 |